Comparison of moisturizing creams for the prevention of atopic dermatitis relapse: A randomized double-blind controlled multicentre clinical trial

Acta Dermato-Venereologica

Volumn 95, Issue 5, 2015, Pages 587-592

  Åkerström, Ulf ^a   Reitamo, Sakari ^b   Langeland, Tor ^c   Berg, Mats ^d   Rustad, Lisbeth ^e   Korhonen, Laura ^f   Lodén, Marie ^g   Wirén, Karin ^a   Grände, Mats ^a   Skare, Petra ^a   Svensson, Åke ^h  

^a Department of Innovation ACO Hud Nordic AB ^*  (Sweden)

^b UNIVERSITY OF HELSINKI   (Finland)

^c Hudlege Tor Langelands kontor   (Norway)

^d Malar Hospital   (Sweden)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^f TAMPERE UNIVERSITY HOSPITAL   (Finland)

^g Eviderm Institute AB   (Sweden)

^h LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atopic dermatitis; Atopic eczema; Emollients; Moisturizer; Prevention; Urea

Indexed keywords

GLYCEROL; HYDROCORTISONE ACETATE; MOMETASONE FUROATE; PLACEBO; SKIN CREAM; UREA; DERMATOLOGICAL AGENT; EMOLLIENT AGENT;

ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; BURNING SENSATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ECZEMA; ERYTHEMA; EYE DISCHARGE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RELAPSE; RISK REDUCTION; ADOLESCENT; CLINICAL TRIAL; COMPARATIVE STUDY; CROSSOVER PROCEDURE; DERMATITIS, ATOPIC; FOLLOW UP; INTRADERMAL DRUG ADMINISTRATION; KAPLAN MEIER METHOD; MIDDLE AGED; PROCEDURES; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PSYCHOLOGY; QUALITY OF LIFE; RECURRENT DISEASE; RISK ASSESSMENT; SECONDARY PREVENTION; SEVERITY OF ILLNESS INDEX; SWEDEN; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-OVER STUDIES; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; EMOLLIENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUALITY OF LIFE; RECURRENCE; RISK ASSESSMENT; SECONDARY PREVENTION; SEVERITY OF ILLNESS INDEX; SWEDEN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84928152035     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-2051     Document Type: Article

References (31)

1. Bieber T. Atopic dermatitis. N Engl J Med 2008; 358: 1483-1494.
2. Halvarsson K, Loden M. Increasing quality of life by improving the quality of skin in patients with atopic dermatitis. Int J Cosmet Sci 2007; 29: 69-83.
3. Spergel JM. From atopic dermatitis to asthma: the atopic march. Ann Allergy Asthma Immunol 2010; 105: 99-106; quiz 107-109, 117.
4. Dharmage SC, Lowe AJ, Matheson MC, Burgess JA, Allen KJ, Abramson MJ. Atopic dermatitis and the atopic march revisited. Allergy 2014; 69: 17-27.
5. Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000; 4: 1-191.
6. Burr S. Emollients for managing dry skin conditions. Prof Nurse 1999; 15: 43-48.
7. Lewis-Jones S, Mugglestone MA. Management of atopic eczema in children aged up to 12 years: summary of NICE guidance. BMJ 2007; 335: 1263-1264.
8. Holden C, English J, Hoare C, Jordan A, Kownacki S, Turnbull R, et al. Advised best practice for the use of emollients in eczema and other dry skin conditions. J Dermatolog Treat 2002; 13: 103-106.
9. Giordano-Labadie F, Cambazard F, Guillet G, Combemale P, Mengeaud V. Evaluation of a new moisturizer (Exomega milk) in children with atopic dermatitis. J Dermatolog Treat 2006; 17: 78-81.
10. Draelos ZD. The effect of ceramide-containing skin care products on eczema resolution duration. Cutis 2008; 81: 87-91.
11. Szczepanowska J, Reich A, Szepietowski JC. Emollients improve treatment results with topical corticosteroids in childhood atopic dermatitis: a randomized comparative study. Pediatr Allergy Immunol 2008; 19: 614-618.
12. Lucky AW, Leach AD, Laskarzewski P, Wenck H. Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol 1997; 14: 321-324.
13. Buraczewska I, Berne B, Lindberg M, Torma H, Loden M. Changes in skin barrier function following long-term treatment with moisturizers, a randomized controlled trial. Br J Dermatol 2007; 156: 492-498.
14. Held E, Sveinsdottir S, Agner T. Effect of long-term use of moisturizer on skin hydration, barrier function and susceptibility to irritants. Acta Derm Venereol 1999; 79: 49-51.
15. Zachariae C, Held E, Johansen JD, Menne T, Agner T. Effect of a moisturizer on skin susceptibility to NiCl2. Acta Derm Venereol 2003; 83: 93-97.
16. Andersson A-C Lindberg M, Lodén M. The effect of two urea-containing creams on dry, eczematous skin in atopic patients. I. Expert, patient and instrumental evaluation. J Dermatolog Treat 1999; 10: 165-169.
17. Loden M, Andersson AC, Lindberg M. Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm). Br J Dermatol 1999; 140: 264-267.
18. Lodén M BE, Mandahl P, Wessman C. The influence of urea treatment on skin susceptibility to surfactant-induced irritation: a placebo-controlled and randomized study. Exogenous Dermatol 2004; 3: 1-6.
19. Loden M. Barrier recovery and influence of irritant stimuli in skin treated with a moisturizing cream. Contact Dermatitis 1997; 36: 256-260.
20. Wiren K, Nohlgard C, Nyberg F, Holm L, Svensson M, Johannesson A, et al. Treatment with a barrier-strengthening moisturizing cream delays relapse of atopic dermatitis: a prospective and randomized controlled clinical trial. J Eur Acad Dermatol Venereol 2009; 23: 1267-1272.
21. Loden M, Wiren K, Smerud K, Meland N, Honnas H, Mork G, et al. Treatment with a barrier-strengthening moisturizer prevents relapse of hand-eczema. An open, randomized, prospective, parallel group study. Acta Derm Venereol 2010; 90: 602-606.
22. Rajka G, Langeland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol 1989; Suppl. 144: 13-14.
23. Loden M, Andersson AC, Anderson C, Bergbrant IM, Frodin T, Ohman H, et al. A double-blind study comparing the effect of glycerin and urea on dry, eczematous skin in atopic patients. Acta Derm Venereol 2002; 82: 45-47.
24. Loden M, Wessman W. The influence of a cream containing 20% glycerin and its vehicle on skin barrier properties. Int J Cosmet Sci 2001; 23: 115-119.
25. Kaplan E MP. Non-parametric estimation from incomplete observations. J Am Stats Assoc 1958; 53: 457-481.
26. Grether-Beck S, Felsner I, Brenden H, Kohne Z, Majora M, Marini A, et al. Urea uptake enhances barrier function and antimicrobial defense in humans by regulating epidermal gene expression. J Invest Dermatol 2012; 132: 1561-1572.
27. Loden M. Urea-containing moisturizers influence barrier properties of normal skin. Arch Dermatol Res 1996; 288: 103-107.
28. Hjalte F, Asseburg C, Tennvall GR. Cost-effectiveness of a barrier-strengthening moisturizing cream as maintenance therapy vs. no treatment after an initial steroid course in patients with atopic dermatitis in Sweden - with model applications for Denmark, Norway and Finland. J Eur Acad Dermatol Venereol 2010; 24: 474-480.
29. Schario M, Lunnemann L, Stroux A, Reisshauer A, Zuberbier T, Blume-Peytavi U, et al. Children with dry skin and atopic predisposition: daily use of emollients in a participant-blinded, randomized, prospective trial. Skin Pharmacol Physiol 2014; 27: 208.
30. Simpson EL, Berry TM, Brown PA, Hanifin JM. A pilot study of emollient therapy for the primary prevention of atopic dermatitis. J Am Acad Dermatol 2010; 63: 587-593.
31. Simpson EL, Chalmers JR, Hanifin JM, Thomas KS, Cork MJ, McLean WH, et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol 2014; 134: 818-823.